Video: Fellow Eye Data Supports GA Clinical Trial Design

At ASRS, Diana Do, MD, presented results of a post hoc analysis of the OAKS and DERBY trials of geographic atrophy growth rates in untreated eyes vs sham eyes.

By: Diana V. Do, MD, Roger A. Goldberg, MD, MBA

Retinal Physician August 9, 2025

Diana V. Do, MD

Retina Specialist

Specialties: Ophthalmology

Bio: Diana V. Do, MD, is a retina specialist and author for Retinal Physician. Her work focuses on ophthalmology and retinal disease, with interest in clinical trials, practice management, and emerging therapies for retinal conditions. In her Retinal Physician column, Dr. Do discusses developments in retina care, including clinical research collaboration, international clinical trial infrastructure, and investigational treatments for neovascular age-related macular degeneration and diabetic macular edema. She has also referenced her training connections with the Wilmer Eye Institute.

Roger A. Goldberg, MD, MBA

Specialties: Ophthalmology

Bio: Roger A. Goldberg, MD, MBA, is a retina specialist featured in Retinal Physician’s Peer Perspectives series on advances in the care of macular telangiectasia type 2. In the discussion, he addressed the definition, progression, diagnostic challenges, and patient impact of MacTel, emphasizing its neurodegenerative features involving Müller glial cell dysfunction and degeneration.

PentaVision

Retinal Physician

Video: Fellow Eye Data Supports GA Clinical Trial Design

Recommendations